miR-125a-3p inhibits ERα transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor-positive breast cancer

MLA

Xiaoman Li, et al. “MiR-125a-3p Inhibits ERα Transactivation and Overrides Tamoxifen Resistance by Targeting CDK3 in Estrogen Receptor-Positive Breast Cancer.” FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, vol. 32, no. 2, Sept. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....39b5729df0bb838e7fdfd12fdeb50595&authtype=sso&custid=ns315887.

APA

Xiaoman Li, Chenxi Xiang, Cheng Li, Lufeng Zheng, Yan Zhang, Yingying Xing, Xia Meng, Tao Xi, & Yufeng Xia. (2017). miR-125a-3p inhibits ERα transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor-positive breast cancer. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, 32(2).

Chicago

Xiaoman Li, Chenxi Xiang, Cheng Li, Lufeng Zheng, Yan Zhang, Yingying Xing, Xia Meng, Tao Xi, and Yufeng Xia. 2017. “MiR-125a-3p Inhibits ERα Transactivation and Overrides Tamoxifen Resistance by Targeting CDK3 in Estrogen Receptor-Positive Breast Cancer.” FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 32 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....39b5729df0bb838e7fdfd12fdeb50595&authtype=sso&custid=ns315887.